OrphanDrug
OrphanDrug
Pharma Knowledge Base

cyanide-induced parkinsonism

ORPHA: 306692

Contents

  1. 1. Overview
  2. 2. Available Treatments
  3. 3. Clinical Presentation
  4. 4. Classification & Codes

Overview

human disease

Available Treatments (0)

No treatments linked yet

Clinical trials or compassionate use may be available — consult a specialist.

Clinical Presentation

Signs and symptoms associated with cyanide-induced parkinsonism, sourced from HPO and Orphanet clinical annotations.

Mask-like faciesApathyDysarthriaParkinsonismRigidityBradykinesiaCerebral cortical atrophyAbnormal speech patternPostural instabilityResting tremorShuffling gaitAnarthriaFallsElbow flexion contractureDecreased facial expressionGeneralized hyperreflexiaShort stepped shuffling gaitHypometric horizontal saccadesAbnormal skin morphologySubcortical cerebral atrophy

Classification & Codes

Orphanet Code

ORPHA:306692
cyanide-induced parkinsonism
OrphanetORPHA:306692
Treatments0 drug(s)
Symptoms on record20 signs
Statuspublished
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO